Back to Journals » OncoTargets and Therapy » Volume 11

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway

Total article views   HTML views PDF downloads Totals
7,972 Dovepress* 7,207+ 743 7,950
PubMed Central* 765 219 984
Totals 7,972 962 8,934
*Since 30 July 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar